Expression of SV-40 T antigen in the small intestinal epithelium of transgenic mice results in proliferative changes in the crypt and reentry of villus-associated enterocytes into the cell cycle but has no apparent effect on cellular differentiation programs and does not cause neoplastic transformation by unknown
Expression of SV-40 T Antigen in the Small Intestinal Epithelium 
of Transgenic Mice Results in Proliferative Changes in the 
Crypt and Reentry of Villus-associated Enterocytes into the Cell Cycle 
but Has No Apparent Effect on Cellular Differentiation Programs 
and Does Not Cause Neoplastic Transformation 
Sherrie M. Hauft,* Steve H. Kim,~ Gtinter H. Schmidt,** Shirley Pease,** Stephen Rees,** 
Stephen Harris,** Kevin A. Roth,w  J. Randall Hansbrough,1 Steven M. Cohn,1 Dennis J. Ahnen,~ 
Nicholas A. Wright,w167  Robert A. Goodlad,~O and Jeffrey I. Gordonlll 
Departments of *  Pediatrics, r Surgery, w  Pathology, II Molecular Biology and Pharmacology,  and I Medicine, Washington University 
School of Medicine, St. Louis, Missouri 63110; ** Department of Genetics, Glaxo Group Research Limited, Middlesex, 
UB60HE, England; and r  of Medicine, Denver Department of Veterans Affairs Medical Center and University of 
Colorado School of Medicine, Denver, Colorado 80220; and w  w  Histopathology Unit, Imperial Cancer Research Fund, 
London WC2A 3PN, England 
Abstract.  The mouse intestinal epithelium represents 
a unique mammalian system for examining the rela- 
tionship between cell division, commitment, and 
differentiation. Proliferation and differentiation are 
rapid, perpetual, and spatially well-organized pro- 
cesses that occur along the crypt-to-villus axis and 
involve clearly defined cell lineages derived from a 
common multipotent stem cell located near the base of 
each crypt. Nucleotides -1178 to  +28 of the rat in- 
testinal fatty acid binding protein gene were used to 
establish three pedigrees of transgenic mice that ex- 
pressed SV-40 large T antigen (TAg) in epithelial cells 
situated in the uppermost portion of small intestinal 
crypts and in already committed, differentiating entero- 
cytes as they exited these crypts and migrated up the 
villus. T antigen production was associated with in- 
creases in crypt cell proliferation but had no apparent 
effect on commitment to differentiate along entero- 
cytic, enteroendocrine, or Paneth cell lineages. Single- 
and multilabel-immunocytochemical studies plus RNA 
blot hybridization analyses suggested that the differen- 
tiation programs of these lineages were similar in 
transgenic mice and their normal litterrnates. This in- 
cluded enterocytes which, based on the pattern of 
[3H]thymidine  and 5-bromo-2'-deoxyuridine labeling 
and proliferating nuclear antigen expression, had re- 
entered the cell cycle during their migration up the 
villus. The state of cellular differentiation and/or TAg 
production appeared to affect the nature of the cell cy- 
cle; analysis of the ratio of S-phase to M-phase cells 
(collected by metaphase arrest with vincristine) and of 
the intensities of labeling of nuclei by [3H]thymidine 
indicated that the duration of S phase was longer in 
differentiating, villus-associated enterocytes than in the 
less well-differentiated crypt epithelial cell population 
and that there may be a block at the G2/M boundary. 
Sustained increases in crypt and villus epithelial cell 
proliferation over a 9-mo period were not associated 
with the development of gut neoplasms-suggesting 
that tumorigenesis in the intestine may require that the 
initiated cell have many of the properties of the gut 
stem call including functional anchorage. 
T 
HE manner in which epithelial cell renewal occurs in 
the mouse intestine provides a unique opportunity to 
address questions about the relationships between cell 
division and differentiation programs in a mammalian sys- 
tem. The opportunity  arises because of three features:  (a) 
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proliferation and differentiation in the gut are spatially well 
organized along the crypt-to-villus axis; (b) the processes oc- 
cur rapidly (completed in •3  d) and perpetually; and (c) cell 
lineage relationships are well known and involve derivation 
from a single, active multipotent  stem cell. 
Each adult small intestinal villus contains a steady state 
level  of several  thousand surface epithelial  cells  (7,000- 
2,000  depending upon its location  along the duodenal-to- 
ileal axis) and is surrounded by '~14 (duodenum) to 6 (ileum) 
flask-shaped crypts of  Lieberkfihn (Wright and Irwin, 1982). 
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small intestine. Each contains 350-550 epithelial cells. Ap- 
proximately 150 of these cells, situated in the mid-portion 
of the crypt, pass through the cell cycle every 12 h resulting 
in an average production rate of 300 new cells/day/crypt 
(Potten and Loeffier, 1990).  In adult animals, each crypt is 
monoclonal (Ponder et al.,  1985;  Schmidt et al.,  1988):  a 
multipotent stem cell, functionally anchored near the base 
of the crypt, gives rise to descendants (a transit stem cell 
population) that proliferate and ultimately yield terminally 
differentiated, nonproliferating columnar absorptive entero- 
cytes, mucus-producing goblet cells, a complex population 
of enteroendocrine cells, and defensin/lysozyme-producing 
Paneth cells (Cheng and Leblond, 1974; Winton et al., 1988, 
1990; Roth et al., 1991b). Paneth cells complete their differ- 
entiation program as they descend to the base of each crypt. 
Enterocytes, goblet cells, and enteroendocrine cells undergo 
differentiation/maturation  as they migrate in vertical, coher- 
ent bands up adjacent (polyclonal) villi (Cheng and Leblond, 
1974; Schmidt et al., 1985).  12 cells exit the crypt per hour 
and move up the villus at the remarkable velocity of  0.75 cell 
diameters per hour. It takes ",,3 d to complete the journey 
to the apical portion of the villus where ~,,1,400 cells subse- 
quently undergo exfoliation into the gut lumen/villus/day 
(Potten and Loeflter, 1990). 
A number of intriguing questions about intestinal epithe- 
lial  differentiation/proliferation can  be  posed.  Is  passage 
through the cell cycle a major regulator of  the ill-defined pro- 
cess of  commitment? Does such passage serve as a ~unctua- 
tion" point by which committed cells are able to mark their 
entrance into a differentiation program? Should differentiation 
(i.e., the noncyclic acquisition of new gene products; Potten 
and Loeffler, 1990) be viewed as a series of irreversible bi- 
nary decisions or the result of continuous active regulation 
(Blau and Baltimore, 1991)? What are the relative dependen- 
cies  of the  differentiation program  on position occupied 
along the crypt-to-villus axis or on time? If the temporal fac- 
tor is important, is it measured from the moment of passage 
through the cell cycle, from the time of exit from the crypt, 
or do other parameters serve as markers? Is there a way of 
separating the effects of time and space (position) on differ- 
entiation? Finally, when the balance between proliferation 
and differentiation is lost during neoplastic transformation, 
how is the initiated cell able to achieve functional anchorage 
for a period sufficient to allow clonal amplification? 
We have generated a transgenic mouse model to explore 
several of these questions. Expression of  the mouse intestinal 
fatty acid binding protein gene (Fabpi) I is gut-specific, cell- 
specific, region-specific, and developmental stage-specific: 
(a) expression is activated as enterocytes emerge from the 
crypt and sustained throughout their subsequent transloca- 
tion to the apical extrusion zone of the villi; (b)  highest 
steady state levels of its mRNA and protein products are at- 
tained in the jejunum, with a progressive fall occurring as 
one proceeds to the proximal colon; and (c) transcription is 
initiated in late gestation coincident with cytodifferentiation 
of  the  epithelium  and  the  emergence  of  nascent  villi 
(Sweetser  et al.,  1988b;  Rubin et al.,  1991). 
1.  Abbreviations  used  in  this paper:  BrdUrd,  5'-bromo-2'deoxyuridine; 
Fabpi, fatty acid binding protein gene; I-FABP, intestinal fatty acid binding 
protein; L-FABP, liver FABP; PCNA, proliferating cell nuclear antigen; 
TAg, T antigen. 
Previous studies in transgenic mice indicated that nucleo- 
tides  -1178 to  +28 of rat Fabpi (I-FABP  -1178 to  +28; 
Sweetser et al., 1987) contain all of the necessary cis-acting 
elements to recapitulate the differentiation-dependent pat- 
terns of expression of the intact, endogenous mouse gene as 
well  as  its  geographic  specificity along the  duodenal-to- 
colonic axis (Sweetser et al., 1988b).  SV-40 T antigen (SV- 
40 TAg) is a multifunctional transforming protein that binds 
to two tumor suppressors - p53 and the retinoblastoma sus- 
ceptibility gene product, Rb (Finlay et al., 1989; DeCaprio 
et al., 1988; Dyson et al., 1990; Ludlow et ai., 1990). Large 
T antigen can eliminate proliferation controls which operate 
in the GI phase of the cell cycle (reviewed in Pardee, 1989). 
We reasoned that by linking nucleotides -1178 to +28 of rat 
Fabpi to the portion of the SV-40 genome encoding TAg and 
using the  resulting chimeric gene  to  produce transgenic 
mice, production of  this 708 residue polypeptide could be in- 
duced coincident with exit of enterocytes from the crypt. 
Such differentiation-dependent activation of transgene ex- 
pression would, in turn, offer the opportunity for determin- 
ing whether committed/differentiating enterocytes can re- 
enter the cell cycle even if they occupy a position in the lower 
to mid-villus, whether such reentry affects the differentiation 
program, and finally whether functional anchorage of such 
cells can occur in the continuously renewing epithelium and 
tumor formation ensue. 
Materials and Methods 
Production of Transgenic Mice with 
i.FABP-~lrs  ~ +  zs/SV.40 TAg Fusion Genes 
A  2.7-kb  BamHI/BglI fragment spanning nucleotides 2533-5235  of the 
SV-40  genome was ligated to a  5.6-kb  BamHI  fragment obtained from 
pIFhGH2 (Swectser et al., 1988b)  using a BamHI/BglI adaptor (5'GATC- 
CCT3'). A 3.9-kb EcolU/SalI fragment containing the I-FABP  -uTs ~o +2s/ 
SV-40 TAg fusion gene was then injected into recently fertilized B6D2Fl 
x  B6D2Ft  or  FVB/N  oocytes.  Four  founders  ((}o13 and  (}o30  from 
B6D2F1  x  B6D2Ft oocytes and (3o48 and (}o103 from FVB/N [Taketo et 
al., 1991] oocytes) were identified after Southern blot analyses of tail DNA 
obtained from 135 live bern mice (32 from B6D2F1  x  B6D2F1  oocytes 
and 103 from FVB/N oocytes). Lines were established from each of these 
founders. Southern blot analysis of tail DNAs obtained from F1 mice indi- 
cated that the transgene copy number was <5 per haploid genome in Go13-, 
(3o30-, and Go48-derived animals and t00 in the Go103  pedigree. FI-F3 
male and female mice from all lines were maintained on a standard chow 
diet given ad libitum and under a strictly controlled light cycle (lights on 
at 0700, off at 1900  h). They were subsequently sacrificed by cervical dislo- 
cation at ages ranging from 50 to 260 d for one or more of the studies de- 
scribed  below. 
RNA Blot Hybridization Studies 
After the mice were killed, the gastrointestinal tract was rapidly subdivided 
as described in Sweetscr et al. (1988a)  and the eight segments were frozen 
in liquid N2.  Nine extra-intestinal tissues were also recovered from each 
mouse (brain, heart, lung, skeletal muscle, kidney, liver, spleen, pancreas, 
and gonads). Total cellular RNA was prepared from each tissue or intestinal 
segment  using  the  guanidine  isothiocyanate/cesium  chloride  method 
(Chirgwin et  al.,  1979).  RNA  integrity was established by denaturing 
methylmercury (Thomas, 1980) or formaldehyde agarose gel electrophore- 
sis. Northern or quantitative RNA dot blot hybridizations were performed 
using [32p]-labeled  rat I-FABP eDNA, rat liver fatty acid binding protein 
(L-FABP) eDNA, and SV-40 TAg DNA probes plus the hybridization and 
washing conditions detailed in our earlier publications (Sweetser ctal., 
1988a,b). The steady state level of  a specific mRNA in samples of  total cel- 
lular RNA was calculated from the intensities of signals generated by in 
vitro transcribed mRNA standards (0.1-500 pg) that were included in each 
dot blot (Swcetser et at.,  1988a,b). Blots were scanned with a laser den- 
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calculations of mRNA abundance. 
Immunocytochemical Studies 
Analysis of I-FABP, L-FABP, Alkaline Phosphatase, Lysozyme, and Neu- 
roendocrine Gene ~ion  in Intestinal Epithelial Cells. 5-10-mm sec- 
tions were recovered from the mid-portions of each intestinal segment be- 
fore freezing and RNA extraction. These sections were fixed in Bouin's fluid 
and embedded in paraffin. 5-#m-thick sections were cut from material that 
had been embedded in paraffin, processed as described in Roth et al. (1990), 
and then surveyed with a panel of polyclonal antisera that have been exten- 
sively characterized (Roth et al.,  1990,  1991a,b;  Roth and Gordon,  1990: 
Rubin et al.,  1991; Young et al.,  1981a,b).  Antigen-antibody complexes 
were visualized using gold-labeled goat anti-rabbit IgG serum and silver 
enhancement (Amersham, Arlington Heights, IL) or secondary antibodies 
labeled with either fluorescein or Texas  red (Jackson ImmunoResearch 
Laboratories, West Grove, PA). Double-label immunofluorescence studies 
were also performed according to Roth et al. (1990).  To quantitate expres- 
sion of neuroendocrine products in the entervendocrine cells of transgenic 
mice (n =  5) and their normal littermates (n =  4), 5-10 sections from the 
proximal jejunal segment of each animal were examined with each antibody 
and the total number of positive cells per cross section was determined. 
Each  positive cell  was  also  classified as  being either crypt- or  villus- 
associated (see Roth et al.,  1990). 
Distribution  of SV-dO TAg. 10-#m-thick  cryostat sections,  prepared 
from duodenal, jejunal, and ileal  segments that had been frozen in OCT 
compound, were fixed for 10 rain at -20~  in acetone. Sections were sub- 
sequently incubated for 1 h at room temperature with either a mouse mAb 
or a hamster antiserum directed against SV--40  TAg (mAB 421 and the ham- 
ster antiserum were kindly supplied by J. Pipas [University of Pittsburgh]; 
final dilution of each =  1:1,000). Antigen-antibody complexes were visual- 
ized using the ABC peroxidase method or by fluorescein-labeled rabbit anti- 
hamster serum (Jackson lmmunoResearch Laboratories). 
Studies  Involving  Proliferating  Cell Nuclear Antigen.  Segments of 
duodenum, proximal and distal jejunum,  and ileum were removed from 
three control and three transgenic mice (3.5-9 mo of age, derived from 
Go13,  see  below),  fixed  in  10%  buffered  formalin,  and  embedded  in 
paraffin. 5-#m sections were cut, deparaffinized in xylene, hydrated, and 
then washed in  PBS.  Sections were incubated with  10%  normal rabbit 
serum for 10 rain at room temperature, washed in PBS, and overlaid with 
a 1:10 dilution of a mAb to proliferating cell nuclear antigen (PCNA) (PC- 
10; Dako, Santa Barbara, CA; Hall et al., 1990).  After a 35-rain incubation 
followed by a PBS wash, sections were overlaid (for 30 min) with a  1:300 
dilution of a biotinylated rabbit anti-mouse immunoglobulin sera (Dako- 
patts, Denmark). They were then washed in PBS and incubated with perox- 
idase-labeled avidin. After another series of PBS washes, sections were in- 
cubated with diaminobenzidine (0.5  mg/ml) containing 0.03%  hydrogen 
peroxide for 3 rain at room temperature. Sections were subsequently washed 
and counterstained with hematoxylin. The PCNA labeling index of crypt- 
and villus-associated cellular populations was determined by dividing the 
number of PCNA-labeled nuclei by the total number of nuclei present in 
longitudinally oriented crypt or villus units (Hall ct al.,  1990). 
Multilabel  lmmunotTtochemical  Studies  of  the  Colocalization  of 
I-FABP  and Bromodeoxyuridine  in Villus-ossociated Enterocytes Labeled 
in S-phase  with  the Nucleotide  Analogue.  Mice were given an  intra- 
peritoneal  injection  of  a  solution  containing  5'-bromo-2'-deoxyuridine 
(BrdUrd, 120 mg/kg) and 5'-fluoro-deoxyuridine (12 mg/kg) 90 rain before 
they were killed. Tissues were removed, fixed in Bouin's fluid, embedded 
in paraffin and 5-#m sections prepared. After removal of paraffin, sections 
were incubated overnight at 4~  with goat anti-BrdUrd serum (Cohn and 
Lieberman, 1984) and rabbit anti-l-FABP serum (Sweetser et al.,  1988b). 
After a series of washes with PBS, antibody-antigen complexes were iden- 
tiffed with fluorescein-labeled donkey antigoat and Texas red-labeled don- 
key antirabbit sera, respectively. 
Calculation of  Duodenal Mitotic and ['H]Thymidine 
Labeling Indices 
Three Gol3-derived transgenic mice (age =  3.5,  8, and 9 too) and three 
normal littermates were injected intraperitoneally with 1 #g/g vincristine 
sulfate (David Bull Laboratories, UK) at 0900 h followed by an injection 
of [3H]thymidine (2  Ci/mmol;  1 #Ci/g of body weight, Amersham) 1 h 
later.  I h after the radiolabeled nucleotide was infused, animals were killed 
by cervical dislocation. The entire gastrointestinal tract (i.e., stomach to 
distal colon) was removed, rapidly blotted, and weighed. After regional dis- 
section, segments were either fixed and stored in neutral buffered formalin 
or fixed in Carnoy's fluid and stored in 70%  (vol/vol)  ethanol. 
To determine the mitotic index, fixed duodenal segments were hydrated 
by incubation in a solution of 50% ethanol for 10 min at room temperature 
followed by 25 % ethanol (again for 10 win). Segments were then hydrolyzed 
in 1 M HCI at 60~  for 12 min and subsequently stained in Sehiffs reagent. 
After this last step, tissue was transferred to 45 % acetic acid, gently teased 
apart under a dissecting microscope and squashed with a coverslip. The 
number of arrested metaphases was noted in 20 duodenal crypts and villi 
(Goodlad and Wright, 1982) for each of the three transgenic and three nor- 
real mice surveyed. 
To calculate the labeling index, formalin-fixed segments of duodenum 
harvested from the three (3o13 transgenics and  their normal  littermates 
were embedded in paraffin. 5-#m sections were cut, mounted, and then 
dipped in Ilford K2 emulsion (Ilford Ltd., Cheshire, UK). After a 3-wk ex- 
posure, autoradiographs were developed and stained with hematoxylin and 
eosin. The number of labeled cells was quantitated in at least 10 duodenal 
villi per animal after first using an eyepiece graticule to divide the villus 
into five zones of equal length. A labeling index (percent of cells labeled) 
was also derived after scoring 20 crypts per mouse. 
Grain Counts 
Autoradiographs of the duodenum were examined using a  100x objective 
and the number of silver grains directly overlying the nuclei of 50 duodenal 
villus- or 20 crypt-associated epithelial cells was scored in each of the three 
transgenic animals studied. All cells were selected at random. 
Morphometric Analysis 
Microdissected crypts were examined under a compound microscope and 
the outline of villi or crypts traced using a drawing tube. Villus or crypt 
outlines were then digitized with a Macintizer ADB graphics tablet (SSI 
Ltd., Pewsey, Wiltshire) connected to an Apple Macintosh computer run- 
ning MacSterology software (Ranfurly Microsystems, Airdrie, UK). The 
crypt-to-villus ratio was determined by counting the number of crypt necks 
or villus bases per low power field (16X objective) in duodenal, proximal 
jejunal, distal jejunal, and ileal segments after they were bulk stained with 
the Feulgen reaction. 
Gross and Microscopic Surveys of the 
I178to +28  Gastrointestinal Tracts of I-FABP-  /SV-40 
TAg Mice for Neoplasms 
Male and female transgenic mice (n =  21  mice, 2-9 mo of age, from the 
Go13, (3o48, and Go103 pedigrees) were killed by cervical dislocation and 
their gastrointestinal tracts removed. After fixation, the epithelium in each 
longitudinally incised segment was inspected under the dissecting micro- 
scope. 5-10-#m sections were also prepared from paraffin embedded or fro- 
zen samples of these segments and stained with hematoxylin and eosin for 
histologic analysis. 
Results 
Nucleotides 1178 to +28 of rat Fabpi Direct 
Expression of  SV-40 TAg to the Intestinal Epithelium 
of Transgenic Mice 
Four pedigrees of transgenic mice were established contain- 
ing  I-FABP  -N78  ,o 2s/SV_40 TAg.  Tissue-specific and  cell- 
specific patterns of transgene expression were analyzed in 
adult Fro-F2 mice from each of the lines. Dot and Northern 
blot hybridization studies of  total cellular RNA isolated from 
stomach,  small  intestine,  colon,  pancreas,  brain,  heart, 
lung, liver, spleen, kidney, skeletal muscle, and testes indi- 
cated that TAg mRNA was confined to the intestine of adult 
animals derived from Gol3, 48, and  103 (data not shown). 
Adult mice from the other line (Go30) did not contain de- 
tectable levels of TAg mRNA in any of these 12 tissues. Re- 
gional dissection of the gastrointestinal tract allowed us to 
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along the duodenal to colonic axis of Go  13-derived I-FABP  lint~  +2s/ 
SV-40 TAg transgenic mice (=) and their normal littermates (u). 
Values were determined by quantitative RNA dot blot hybridiza- 
tions. Results obtained from each animal (n = four transgenic mice 
3-9 mo of age and four of their normal littermates) are indicated 
by a o. The asterisk indicates that the mRNA was not detectable 
in total cellular RNA prepared from this segment in any of the ani- 
mals surveyed (limits of detection =  0.2 Pg/t~g). DU, duodenum; 
PJ, proximal jejunum; D  J, distal jejunum; IL, ileum; CE, cecum; 
PC, proximal colon; DC, distal colon. A two-tailed t-test revealed 
no significant differences in L-FABP mRNA levels between trans- 
genic and normal mice in any of the intestinal segments surveyed 
(P > 0.05). While the relative distribution of I-FABP mRNA along 
the duodenal-to-colonic axis was not significantly different between 
the two groups, statistically significant (P < 0.01) quantitative dif- 
ferences were found in the proximal jejunal and ileal segments of 
their small bowels. These differences are not accompanied by ap- 
preciable differences in the steady state concentration of immuno- 
reactive I-FABP in enterocytes located at comparable positions 
along the crypt-to-villus axis (see text). 
define  the  distribution  of  SV-40  TAg  mRNA  along  the 
duodenal-to-colonic axis. The results of quantitative dot blot 
studies  of RNAs  obtained  from four 90-260-d-old  mice 
from line 13 are shown in Fig.  1.  The duodenal-to-colonic 
distribution of SV-40 TAg mRNA closely approximated the 
distribution of I-FABP mRNA (compare the upper and mid- 
dle panels). Highest steady state levels of SV-40 mRNA were 
encountered in the distal jejunum (range =  6-7 pg//xg total 
cellular RNA)  with a  progressive fall occurring from this 
segment  to  the  ileum  (3-5  pg//zg)  and  the  cecum (x<0.4 
pg//xg).  No  TAg  mRNA  was  detectable in  colonic RNA 
(limits of detection of the assay  =  0.2 pg//~g total cellular 
RNA). It is remarkable that the concentration of SV-40 TAg 
mRNA in a given segment varied so little between animals 
even over a  wide range of ages (3-9 mo). 
Northern  blot  analyses  of duodenal,  jejunal,  and  ileal 
RNAs prepared from adult (3-mo-old) descendants of Go48 
and  Go103  revealed  (a)  a  unique  mRNA  species  corre- 
sponding to the known size of SV-40 TAg mRNA in mem- 
bers of these transgenic pedigrees but not in RNA prepared 
from their normal littermates; and (b) a similar distribution 
of TAg mRNA along the duodenal-to-ileal axis compared to 
Gol3-derived  transgenics  despite  their  different  genetic 
backgrounds (data not shown). 
Immunocytochemical staining of proximal jejunum har- 
vested from 3-9-mo-old transgenic mice from the three "ex- 
pressing" pedigrees showed that SV-40 TAg production was 
confined to  enterocytes. Immunoreactive protein was  first 
detectable in the nuclei of cells located in the uppermost 
quarter of the crypt and in the basal portion of  the villus (Fig. 
2 A). Steady state levels were higher in cells situated in the 
middle and upper thirds of small intestinal villi. Fig. 2 B il- 
lustrates that there was little apparent change in the concen- 
tration of this transforming protein as enterocytes migrated 
from the mid to apical portions of several villi situated in the 
proximal jejunum. The distribution of immunoreactive SV- 
40 TAg along the crypt-to-villus axis was similar to that of 
I-FABP (Fig. 2 C). Control experiments established that no 
nuclear (or cytoplasmic) signal was present after incubation 
of the anti-TAg  sera with sections of proximal jejunum har- 
vested from normal littermates or from transgenic mice from 
the SV-40 TAg mRNA-negative line 30 (data not shown). 
Effect of SV-40 TAg Expression on Intestinal 
Epithelial Cell Proliferation 
There were no significant differences in the percent body 
weight of the small intestine or colon of adult 3-9-mo-old 
Gol3-derived transgenic mice compared to their normal lit- 
termates or members of the nonexpressing transgenic pedi- 
gree (two-way ANOVA,  P  >  0.05). 
[3H]Thymidine pulse labeling studies revealed that there 
were no significant differences in the duodenal crypt labeling 
indices  of Gol3-derived  control  mice  compared  to  their 
TAg-expressing transgenic littermates (32  5: 2% versus 33 
+  4%, respectively, see Fig. 3 A). However, the duodenal 
crypts in transgenic mice were significantly longer (Fig.  3 
B), and thus the number of labeled cells per crypt was also 
significantly  increased  (Fig.  3  C).  The 2-h collection of 
metaphases (see Materials and Methods) was also signifi- 
cantly increased (from 19  +  1 to 35  +  5 metaphases per 
duodenal crypt, P < 0.05, Fig. 3 D). The area of the duodenal 
crypts was also significantly greater in transgenic mice (Fig. 3 
E). However, there was no difference  in the number of crypts 
supplying the duodenal (or jejunal,  or ileal) villi between 
transgenic animals and their normal littermates (see crypt to 
villus ratio in Fig. 4 A) nor was there a significant difference 
in the area of their villi (Fig. 4 B). 
No  [3H]thymidine  labeling  of  villus-associated  entero- 
cytes was noted in nontransgenic littermates (i.e., the label- 
ing  index was 0%,  see Fig.  5  A).  In contrast,  there was 
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in epithelial cells distributed  along the crypt-to-villus axis. Sections 
were prepared from the proximal jejunum and stained  with poly- 
clonal hamster serum directed  against  SV-40 TAg (A and B) or a 
.polyclonal antibody specific for I-FABP (C). TAg is first detectable 
in cells  located in the  uppermost portions of the crypt.  Villus- 
associated enterocytes possess both intense nuclear TAg and diffuse 
cytoplasmic  I-FABP immunoreactivity.  (Original  magnification 
x400.) 
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ric indices in I-FABP  HTs to +2s/SV.40 TAg mice and their normal 
littermates. See Materials and Methods for a description of how 
these values were obtained from three Go13 transgenic mice aged 
3-9 mo and three normal littermates. The asterisks (*) indicate that 
the difference  between transgenic and normal mice is statistically 
significant (P < 0.01). 
extensive labeling of enterocytes on the duodenal villi of 
Gol3-derived transgenic animals (Fig. 5 B). The total duo- 
denal villus labeling index for these mice was 12 5:2 % (Fig. 
4 C). The majority of labeled cells were located in the mid- 
portion of duodenal villi where the labeling index averaged 
20% (Fig. 4 C). This latter value approaches the labeling in- 
Figure 4.  Comparison of vil- 
lus labeling and morphomet- 
ric indices in transgenic mice 
and their normal littermates. 
See  Materials and  Methods 
for details.  Note that crypt/ 
villus ratio refers to the num- 
ber  of crypts  that  surround 
duodenal (DU), proximal je- 
junal  (PJ),  distal  jejunal 
(D  J), and ileal (IL) villi. The 
asterisks in D indicate that the 
differences in PCNA labeling 
indices  between  transgenic 
and normal mice are statisti- 
cally significant (P < 0.01) in 
the segment surveyed. 
dex found in normal and transgenic crypts (Fig. 3 A). More- 
over, the mean number of silver grains overlying a nucleus 
in a transgenie villus-associated duodenal epithelial cell was 
28 +  2 % while the mean number of silver grains over a la- 
beled nucleus situated in the crypt was 52 +  4 %. The num- 
ber of villus-associated cells labeled in S phase during the 
1-h pulse of [3H]thymidine decreased as a function of their 
position along the duodenal-to-ileal axis of the small intes- 
tine (Fig. 5, B-D), a decrease which paralleled the decrease 
in TAg expression (Fig.  1). 
The duodenal villus mitotic index in Gol3-derived trans- 
genie mice was 2  5:  1% compared to a value of 18  5:  2% 
in their duodenal crypts. This ninefold difference between 
the duodenal villus' mitotic index and the duodenal crypt's 
mitotic  index  is  greater  than the  threefold difference in 
[3H]thymidine  labeling indices determined simultaneously 
in the same sections (total villus labeling index  =  12%, 
crypt =  33%). Expressed another way, there was a greater 
discrepancy between the number of cells in S and M phase 
in the villus (ratio of labeling index to mitotic index =  6) 
compared to the crypts (ratio of labeling index =  1.8, see 
Fig. 3, A and D). The significance of these observations is 
discussed below. 
Proliferating cell nuclear antigen (PCNA) is a 36-kD nu- 
clear phosphoprotein that functions as a cofactor for DNA 
polymerase-5. It is synthesized in greater amounts during 
S-phase and has a half-life of •  20 h (Bravo and Celis, 1980; 
Celis and Celis,  1985; Bravo and Macdonald-Bravo, 1987; 
Jaskulski et al.,  1988;  Morris and Mathews, 1989;  Chang 
et al., 1990).  PCNA expression can be used to identify the 
proliferative compartment in normal human and rodent in- 
testine (Hall et al.,  1990;  Yamada,  K., K. Yoshitake,  M. 
Sato, and D. Ahnen, unpublished observations). The PCNA 
labeling index was therefore determined for at least 8 (range 
=  8-16)  longitudinally oriented crypts and villi in each of 
the four intestinal segments (duodenum, proximal and distal 
jejunum and  ileum) of Gol3-derived transgenic mice and 
their normal  littermates.  In normal  mice,  PCNA-positive 
cells were largely confined to the crypts. Only occasional 
cells were present in the basal portion of villi (Fig. 6 A). No 
significant differences were noted in the duodenal, jejunal, 
or ileal crypt cell PCNA labeling index were noted between 
control  and  transgenic  animals,  just  as  there  were  no 
significant differences in the crypt cell [3H]thymidine label- 
ing index (Fig. 3 A and data not shown). A highly significant 
(P <  0.001) increase in the villus cell PCNA labeling index 
was found in the duodenum, proximal, and distal jejunum 
of transgenic compared to control mice while no significant 
differences in PCNA expression were detected in their il- 
eums or  colons (Fig.  4  D  and data not shown).  PCNA- 
positive cells were present in highest concentration in the 
mid-portion of duodenal and jejunal villi (Fig. 6, B and C). 
Thus the altered expression of PCNA parallels the expres- 
sion of SV-40 TAg along both axes of the gut. The abnormal 
pattern of PCNA production did not appear to represent a 
"simple" expansion of the PCNA-positive crypt cell popula- 
tion to the villus since levels of this long-lived protein de- 
crease markedly from the upper crypt to the lower portion 
of the villus before rising abruptly in mid-villus (Fig. 6, B 
and C). 
F~ and F2 transgenic mice derived from Go48 and Go103 
were  given  an  intraperitoneal  injection of BrdUrd  (plus 
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beling of villus enterocytes in 
an 8-mo-old transgenic mouse 
producing SV-40  TAg. (A) Sec- 
tion from a normal littermate's 
duodenum showing densely la- 
beled ceils in the crypt but not 
on the villus (￿  (B) sec- 
tion from the duodenum of  the 
transgenic  animal.  The open 
arrow  points to a heavily la- 
beled nucleus in a mid-villus 
enterocyte. The closed arrow 
points  to  a  mitotic  figure 
(x500); (C) section from the 
distal  jejunum  of the  same 
transgenic mouse shown in B. 
Fewer epithelial cells overlying 
the villus are labeled compared 
to  the  duodenal  section 
(x300); (D) section taken from 
the ileum of the Gol3-derived 
transgenic mouse. Silver grains 
are confined to crypt-associ- 
ated cells (￿ 
5'-fluoro-deoxyuridine  to  inhibit  endogenous  thymidylate 
synthetase activity; Brinkman and Dormier, 1972)  1.5 h be- 
fore killing. Sections of their proximal small intestine were 
stained with a goat antibromodeoxyuridine serum (Cohn and 
Lieberman,  1984) or the TAg mAb. The results confirmed 
that TAg producing cells located in the mid-portion of duo- 
denal  and jejunal  villi  (Fig.  7  A)  were also  able  to enter 
S-phase. 
Together the data suggest a number of conclusions. First, 
the similar distributions of TAg, PCNA, and I-FABP along 
duodenal and jejunal villi together with the observed cellular 
patterns  of  [3H]thymidine  and  BrdUrd  labeling  suggests 
that expression of TAg in differentiating enterocytes results 
in their "aberrant" reentry into S-phase (proliferation). Sec- 
ond,  the  twofold difference in  the  mean number of silver 
grains overlying a duodenal crypt nucleus versus a villus nu- 
cleus  (53  v  28,  P  =  0.0065)  indicates  that the  uptake of 
tritiated thymidine during S-phase in the crypts was almost 
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cal survey of  PCNA expression 
along  the  crypt-to-villus  and 
duodenal-to-ileal  axis  of  an 
i_FABpnTs to  +2s/SV_40 TAg 
transgenic mouse and its nor- 
mal littermate. A shows a sec- 
tion  taken  from the  normal 
littermate's duodenum. Immu- 
noreactive PCNA is limited to 
crypt epithelial cells; B shows 
a section from the duodenum 
of the transgenic animal illus- 
trating intense PCNA staining 
of  enterocytes distributed from 
the mid to upper villus. No nu- 
clear staining is detectable in 
enterocytes  located in the lower 
portion of  the villus. (C and D) 
Sections obtained  from prox- 
imal  and  distal  jejunum,  re- 
spectively. The concentration 
of  PCNA-positive  villus epithe- 
lial cells is lower in the distal 
compared to proximal portions 
of  the small intestine. Note that 
there were no significant  differ- 
ences in the crypt cell PCNA 
labeling indices between trans- 
genie mice and/or their normal 
littermates in any of the small 
intestinal  segments  surveyed 
(i.e.,  duodenum, jejunum,  or 
ileum). 
twice that  in  villus  enterocytes  and  suggests  that  cellular 
DNA synthesis was proceeding more slowly in villus entero- 
cytes. The marked differences in duodenal crypt and villus 
mitotic indices "despite" the similarities in their [3H]thymi- 
dine and PCNA labeling indices also supports the fact that 
there may be differences in the kinetics of their cell cycle pro- 
grams (e.g., differentiated TAg-producing villus enterocytes 
may tend to arrest at the G2/M boundary). Third, cell pro- 
liferation  in  the  crypt  was  increased  in  transgenic  mice. 
Since transgene expression was barely detectable in the up- 
per quarter of the crypt, this suggests that crypt epithelial 
cell proliferation may be influenced by levels of SV-40 TAg 
that are below the limits of detection by immunocytochemi- 
cal methods and/or that most of the proliferative increases are 
due to the presence of the reporter in the upper portions of 
the crypt. Fourth, the fact that there was no increase in villus 
area despite the increases in cell proliferation in the crypt 
raises the possibility that there may be increased cell loss on 
the villus. When normal crypt cells go into mitosis, they re- 
duce  their  contact  with  the  basement membrane and  are 
"squeezed" towards the crypt lumen (Tannock, 1967; Loehry 
et  al.,  1969).  However,  there  was  no  evidence  for  this 
phenomenon along the villi of transgenic mice. The presence 
of similar numbers of enterocytes containing the long-lived 
PNCA in the mid and upper portions of duodenal and jejunal 
villi  "despite"  the  sharp  drop  in  nuclear  labeling  with 
[3H]thymidine suggests that reentry into the cell cycle is not 
associated with cellular exfoliation at mid-villus but rather 
with continued migration to the apical extrusion zone. 2 
The Effects of SV-40 TAg Production on Epithelial 
Cell Differentiation Programs 
Since SV-40 TAg production was associated with changes in 
crypt epithelial proliferation, two questions arise:  (a) does 
TAg production have any effect on the processes of commit- 
ment and differentiation of the other, nonenterocytic, gut epi- 
2. While cell migration  pathways  can normally  be directly  quantified  by fol- 
lowing the fate  of a "wave"  of labeled cells  as they migrate  through a villus, 
the abnormal  mitotic activity  of villus enterocytes  makes  the results  of such 
an experimental  approach  difficult, if not impossible, to interpret. 
The Journal of Cell Biology, Volume 117, 1992  832 Figure 7. Single and multi-label immunocytochemical studies of enterocytes in S-phase. Sections were prepared from a 9-mo-old female 
I_FABpUTs to +2s/SV_40 TAg transgenic  mouse  (derived from Go48) 1.5  h  after receiving  an  intraperitoneal  injection of 5'-bromo- 
2'deoxyuridine (BrdUrd). (A) BrdUrd-positive crypt epithelial cells are seen as is a cluster of S-phase cells in mid-villus; (B) distribution 
of I-FABP immunoreactive cells in the same section; (C) dual exposure shows I-FABP positive-enterocytes in S-phase in the mid and upper 
portion of jejunal villi (original magnification x300). 
thelial cell lineages; and (b) what effects does reentry into 
the cell cycle have on differentiation of enterocytes? 
Enterocytes.  Production of SV-40 TAg had no apparent 
effect on the enterocytic differentiation program.  Synthesis 
of SV-40 TAg was not associated with any apparent change 
in  the  cellular distribution,  or  levels,  of immunoreactive 
I-FABP along the crypt-to-villus axis (Fig. 8, A and B). Dou- 
ble  label  experiments  using  antibodies  directed  against 
BrdUrd and I-FABP revealed that entry of villus-associated 
enterocytes into S-phase was not associated with any dis- 
cernible change in the level of this cytoplasmic long chain 
fatty acid binding protein (Fig.  7,  A-C).  [Control experi- 
ments using both normal and transgenic mice demonstrated 
that bromodeoxyuridine-positive  cells located in the mid and 
lower portions of the crypt were I-FABP negative.) The dis- 
tribution of I-FABP mRNA along the duodenal-to-colonic 
axis was also comparable in transgenic mice and their nor- 
mal littermates (middle panel of Fig. 1). The cellular and re- 
gional patterns of expression of several other markers of en- 
terocytic differentiation appeared to be unaffected by SV-40 
TAg production and by entry into S-phase. These markers 
include liver fatty acid binding protein (Figs. 1 and 8, C and 
D) as well as alkaline phosphatase (Fig.  8, E  and F). 
Enteroendocrine Cells. Expression of SV-40 TAg had no 
discernible effect on enteroendocrine cell differentiation pro- 
grams. Fabpi is not normally expressed in enteroendocrine 
cells (Sweetser et al.,  1988b). While enteroendocrine cells 
and enterocytes are apparently derived from the same mul- 
tipotent,  crypt-associated stem  cell  (Cheng and  LeBlond, 
1974; Roth et al., 1991b),  it is not known when, or how, the 
descendants of this stem cell become committed to differen- 
tiate along distinct enterocytic and enteroendocrine lineages. 
In addition, each of the '~15 different enteroendocrine cell 
subpopulations have characteristic distributions along both 
the crypt-to-villus and duodenal-to-colonic axes of the gut. 
Therefore, they collectively provide a  sensitive marker for 
positional differentiation in this continuously renewing epi- 
thelium (Roth et al.,  1990,  1991a;  Roth and Gordon, 1990; 
Rubin et al.,  1991). 
We used single and multilabel immunocytochemical tech- 
niques  to  survey the  proximal jejunal  segments of Go13- 
derived I-FABP  -~ 178 to +2s/SV_40 TAg transgenic mice (n =  5 
animals 3-9 mo of age) and their normal littermates (n  = 
4)  for enteroendocrine subpopulations known to reside in 
this portion of the proximal-to-distal axis of the intestine. 
The results, presented in Table I, indicate that there were no 
statistically significant differences in the number, or crypt- 
to-villus distribution, of serotonin-, substance P-, secretin-, 
gastric  inhibitory  peptide,  cholecystokinin,  and  gastrin- 
immunoreactive cells between the two groups of animals. 
Previous studies (Roth et al.,  1990,  1991a; Roth and Gor- 
don,  1990)  have  suggested  that  differentiation-dependent 
interrelationships exist between enteroendocrine subpopula- 
tions. For example, there appears to be an ordered sequen- 
tial, migration-dependent expression of substance P, seroto- 
nin,  and  secretin as these cells are translocated along the 
crypt-to-villus axis (Roth and Gordon, 1990). The percentage 
of secretin cells containing colocalized serotonin immunore- 
activity (Fig. 8, G-l) was the same in both groups: 53 +  6% 
in transgenic jejunum versus 54 +  3 % in normal littermates. 
Moreover, secretin-immunoreactive cells were confined to 
the villus whether or not SV-40 TAg was expressed in the gut 
epithelium (Table 1 and Fig.  8 G). 
Paneth Cells.  As noted in the introduction, Paneth cell 
differentiation, unlike enterocytic and enteroendocrine cell 
differentiation, proceeds during descent to the base of the 
Hauft et ai. SV-40 T Antigen Expression in Transgenic Mouse Intestine  833 The Journal of Cell Biology, Volume 117,  1992  834 Figure 8.  Expression of cellular differentiation  markers along the crypt-to-villus axis in the jejunum of an 8-mo-old normal (A, C, and 
E) and I-FABP  HTst~  +2s/SV-40 TAg transgenic mouse (B, D, and F).  Sections  were incubated with antisera against  I-FABP (A and B), 
L-FABP (C and D), and alkaline phosphatase (E and F) and detected with Texas red-, fluorescein-,  and gold-labeled secondary antibodies 
(with subsequent  silver intensification  and visualization  with reflected light polarization microscopy), respectively. In all cases, the distribu- 
tion and intensity  of immunoreactivity appeared identical  between control and transgenic  mice.  (Original  magnifications  x400 [.4 and 
B] and x200 [(7, D, E, and F].) Complex enteroendocrine cell interrelationships  appear to be maintained in I-FABP/SV-40 TAg transgenic 
mice. A section from the jejunum of an 8-mo-old transgenic mouse shows a single  secretin  immunoreactive cell in G (visualized  with 
reflected light polarization microscopy). The identical  section was subsequently  stained for serotonin immunoreactivity and shows several 
positive cells (H). Dual exposure of  the secretin and serotonin immunoreactivities  (I) demonstrates colocalization of serotonin and secretin 
(indicated  by an arrow).  Several  other serotonin-immunoreactive cells lack secretin  immunoreactivity.  (Original  magnification  x400). 
Hauft et al. SV-40 T Antigen Expression in Transgenic Mouse Intestine  835 Table L Comparison of  Enteroendocrine Cell Differentiation in the Proximal Jejunum of  I-FABP/SV40 TAg Transgenic 
Mice and their Normal Littermates 
Serotonin  Substance P  Secretin  GIP  CCK  Gastrin 
Number of cells/cross section (x •  SEM) 
Transgenic  128  •  25  52  +  13  40  +  11  32  +  6  47  +  7  41  +  8 
Control  120  +  22  31  +  8  21  +  4  24  +  3  42  +  3  38  •  5 
Percentage of cells associated with villus (x •  SEM) 
Transgenic  61  •  3  42  •  4  100  •  0  64  •  2  67  •  3  71  •  5 
Control  66  •  5  42  :t:  4  100  •  0  63  +  5  71  •  4  69  •  5 
See Materials and Methods for f~rther details. 
crypt. Therefore, examination of the distribution of Paneth 
cells in the crypts of normal and transgenic mice provided 
an opportunity to assess whether the proliferative changes 
produced in the crypts by SV-40 TAg affected this lineage. 
They did not. Staining of duodenal and jejunal sections with 
an  antilysozyme antibody  (Moser et  al.,  1992)  indicated 
Paneth cell number and location were comparable in trans- 
genic mice and their normal littermates (data not shown). 
Expression  of SV-40 TAg in the Gut 
Epithelium of Transgenic Mice Is Not Accompanied 
by Neoplastic  Transformation 
The studies described above suggested that SV-40 TAg ex- 
pression did not result in any detectable dedifferentiation of 
the gut epithelium. Gross and microscopic inspection (see 
Materials and Methods) of  duodenal, jejunal, ileal, cecal and 
colonic segments harvested from 21  male and female mice 
derived from the three pedigrees and ranging in age from 2 
to 9 mo failed to reveal any neoplastic lesions. The relation- 
ship  between  these  findings  and  current  concepts of the 
mechanisms which underlie intestinal epithelial tumorigene- 
sis is discussed below. 
Discussion 
As noted in the introduction, the crypt-to-villus axis of the 
mouse intestinal epithelium represents an attractive mam- 
malian system for examining the relationships between cell 
division  and  differentiation.  In  the  transgenic  model  de- 
scribed  here,  differentiation-activated production  of TAg 
provided an intracellular switch that led to the entry of en- 
terocytes into S phase. Such an entrance presumably reflects 
the fact that SV-40 TAg binds to, and inactivates, the dephos- 
phorylated form of the retinoblastoma susceptibility gene 
product (Ludlow et al.,  1989; 1990). RB is phosphorylated 
at  the  GdS  boundary.  The  dephosphorylated  form  is 
thought to inhibit entry into S phase (Buckovich et al., 1989; 
Chen et al.,  1989;  DeCaprio et al.,  1989). TAg contains a 
domain  that  has  been  identified  in  two  cellular proteins 
(RBP-1 and RBP-2) and two viral transforming proteins (hu- 
man papilloma virus-16 E7 and adenovirus E1A). This con- 
served motif mediates binding  of all  four proteins to the 
same region of RB (Defeo-Jones et al.,  1991). 
Induction of SV-40 TAg expression at a defined temporal 
and spatial point of epithelial cell differentiation/transloca- 
tion along the crypt-to-villus axis allowed us to assess  (a) 
whether the state of differentiation affected the nature of the 
cell cycle; (b) whether reentry into the cell cycle affected 
differentiation of a  specific lineage (enterocytes); and  (c) 
whether proliferative changes  in  the  crypt affected other 
lineages. 
We were not able to determine whether enterocytes that 
entered S-phase in the mid-villus passed through the cell cy- 
cle in its entirety. However, there was a marked discrepancy 
between the number of cells in S-phase and in M-phase on 
the villus compared to the crypt (in the absence of any evi- 
dence for abnormal exfoliation of  enterocytes before their ar- 
rival at the apical extrusion zone). This discrepancy could 
reflect a number of mechanisms. First, the state of differenti- 
ation could influence cell cycle kinetics (prolonging S phase 
or affecting passage through the G2/M boundary) by alter- 
ing the levels of key regulators of  cell cycle induction and cell 
cycle transitions (see Murray and Kirschner,  1989;  McIn- 
tosh and Koonce; 1989; Laskey et al.,  1989;  Hartwell and 
Weinert, 1989 for overviews of these processes). For exam- 
ple, progression from G~ to M phase depends on activation 
of a protein kinase composed of p34  ~'2 and Gt-specific cy- 
clins (Pines and Hunter, 1990). The levels of this kinase and 
its state of phosphorylation may be quite different in crypt 
compared to villus epithelial cell populations. Second, SV- 
40 TAg may itself influence cell cycle kinetics independent 
of, or dependent upon, the state of enterocytic differentia- 
tion. Crossing transgenic animals with I-FABP  -j ~78 ~ +28/S  V_ 
40  TAg  to  mice that  contain  I-FABP  -lm,o  +28  linked  to 
specific cyclins or p34  ~2 may provide a means for examin- 
ing the mechanisms which regulate cell cycle kinetics in en- 
terocytes as they traverse the crypt-to-villus axis. 
Single and double label immunocytochemical studies sug- 
gested  that  TAg-induced entry  into  S-phase  was  not  as- 
sociated with any apparent effect on enterocytic differentia- 
tion. However, this conclusion must be viewed with caution. 
Migration of enterocytes up the villus and exfoliation at the 
apical  extrusion zone may occur too rapidly to allow us 
to detect changes in  the state of differentiation that could 
have been manifested if these cells had a longer residence 
time on the villus. Alternatively, changes may have been de- 
tectable if the turnover times of the differentiation markers 
used for the analysis was more rapid than those of L-FABE 
I-FABP, or alkaline phosphatase. 
Studies of the Drosophila string locus have suggested that 
cell-division programs can be uncoupled from commitment 
and  differentiation programs  (Edgar and  O'Farrell,  1989, 
1990; O'Farrell et al.,  1989). It will be important to estab- 
lish  what  proportion  of villus-associated  enterocytes that 
have entered  S-phase  subsequently  complete  the journey 
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metric (i.e., yielding two daughters with similar phenotypes) 
it would contrast with the asymmetric nature of the division 
of crypt stem cells and their immediate progeny (i.e., yield- 
ing one daughter that remains undifferentiated while the 
other undergoes commitment to differentiate). Increasing 
symmetry of cell division as a function of position along the 
spatially well organized crypt-to-villus axis could be viewed 
as  one  way  of defining commitment and/or  progression 
through a differentiation program. To date, our studies indi- 
cate that SV-40 TAg-induced changes in crypt cell prolifera- 
tion affect a population that is already committed since there 
was no discernible change in the representation of  terminally 
differentiated members of the enterocytic, enteroendocrine, 
or Paneth cell lineages. Expression of SV-40 TAg in the mid 
to lower crypt would represent a way of inducing division in 
cells that are less differentiated and perhaps less commit- 
ted. 3 This could provide a strategy for defining where deci- 
sions about lineage allocation (commitment) are made. 
Sustained expression of SV-40 TAg in the small intestinal 
epithelium is associated with sustained increases in crypt 
and villus epithelial cell proliferation without formation of 
gut epithelial cell neoplasms. This contrasts with results ob- 
tained in other transgenic mice where TAg production in 
nonrenewing cellular populations has yielded a  variety of 
tumors (e.g., Brinster et al.,  1984;  Hanahan, 1985; Ornitz 
et al.,  1987) or where production of other oncoproteins in 
more slowly renewing epithelia produces neoplasia (Bailleul 
et al.,  1990).  The absence of neoplasms in our transgenic 
mice raises several questions concerning initiation, promo- 
tion,  and progression of neoplasia in the gut epithelium. 
Current hypotheses concerning the origin of human colorec- 
tal carcinomas suggest that they arise from a series of accu- 
mulated genetic mutations that affect both protooncogenes 
and tumor suppressor genes (Fearon and Vogelstein,  1990; 
Bodmer et al.,  1987; Leppert et al.,  1987; Kinzler et al., 
1991a,b;  Groden et al., 1991; Joslyn et al., 1991; Fearon et 
al., 1987; Forrester et al., 1987; Bos et al., 1987; Vogelstein 
et al., 1988; Fan" et al.,  1988; Baker et al.,  1989; Nigro et 
al., 1989; Fearon et al., 1990).  Studies of human colorectal 
tumors (Kirkland,  1986, 1988;  van den Ingh et al.,  1986; 
Carroll et al., 1990) as well as several mouse models of gut 
neoplasia (Oomen et al.,  1984;  Moser et al.,  1990,  1992) 
have shown that all four epithelial cell lineages may be repre- 
sented in a given lesion suggesting that the site of initiation 
of tumorigenesis may be the multipotent stem cell or one of 
its immediate descendants.  The lack of gut neoplasms in 
I_FABP-H7s to §  TAg animals could reflect the in- 
ability of  a rapidly migrating "initiated" (TAg producing) cell 
to become functionally anchored and to acquire multiple in- 
dependent or interdependent somatic mutations required for 
dedifferentiation and clonal expansion. In contrast, expres- 
sion of SV-40 TAg in gut stem cells or one of  their immediate 
descendants may represent the equivalent of a single germ- 
line mutational event that is sufficent to produce a neoplasm 
3. Recent work with I-FABP/hGH chimeric genes indicate that reporter ex- 
pression can be precociously activated in epithelial cells located in the lower 
and middle thirds of intestinal crypts by removing elements upstream of 
nucleotide- 184 of rat Fabpi, Cohn, S., T. Simon, K. Rnth, E. Birkenmeier, 
and J. Gordon, unpublished observations). Thus, comparison of mice with 
I.FABPI~ to +2s/sv.40 TAg and I-FABP n7s to +2s/SV.40  TAg transgenes 
may be useful for these types of analyses. 
since this initiated cell can already "provide" an enormous 
division potential, functional anchorage and multipotency. It 
will be interesting to note whether expression of SV-40 TAg 
in gut epithelial cells located outside of the stem cell com- 
partment but with longer residence times than enterocytes 
(e.g.,  certain enteroendocrine cell populations or Paneth 
cells) is sufficient to result in tumor formation (see Rindi et 
al., 1990).  The I-FABP/SV-40 TAg mouse should provide a 
sensitive genetic substrate for auditing the ability of gene 
products to affect such fundamental processes as cell an- 
chorage,  for  assessing  structure/activity  relationships  of 
proteins thought to play a role in the multistep journey to 
colorectal  carcinoma,  for  obtaining cell  lines  that more 
closely resemble enterocytes than currently available  sys- 
tems, and for testing the potential mutagenic effects of ther- 
apeutic agents that are being developed and require chronic 
oral administration. 
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